Title: Mechanisms of transfusion‐induced immunosuppression
Abstract: TransfusionVolume 30, Issue 7 p. 651-658 Mechanisms of transfusion-induced immunosuppression M.E. Brunson, M.E. Brunson Matthew E. Brunson, Research Fellow, Department of Surgery.Search for more papers by this authorJ.W. Alexander MD, Corresponding Author J.W. Alexander MD Professor of Surgery2Department of Surgery, Transplant Division, 231 Bethesda Avenue, Cincinnati, OH 45267–0558Search for more papers by this author M.E. Brunson, M.E. Brunson Matthew E. Brunson, Research Fellow, Department of Surgery.Search for more papers by this authorJ.W. Alexander MD, Corresponding Author J.W. Alexander MD Professor of Surgery2Department of Surgery, Transplant Division, 231 Bethesda Avenue, Cincinnati, OH 45267–0558Search for more papers by this author First published: September 1990 https://doi.org/10.1046/j.1537-2995.1990.30790385527.xCitations: 161 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Gantt CL. Red blood cells for cancer patients (letter). Lancet 1981; 2: 363. 2 Francis DMA, Shenton BK. Blood transfusion and tumour growth: evidence from laboratory animals (letter). Lancet 1981; 2: 871. 3 Schriemer PA, Longnecker DE, Mintz PD. The possible immunosuppressive effect of perioperative blood transfusions in cancer patients. Anesthesiology 1988; 68: 422–8. 4 Wu HS, Little AG. Perioperative blood transfusions and cancer recurrence. J Clin Oncol 1988; 6: 1348–54. 5 Nichols RL, Smith JW, Klein DB, et al. Risk of infection after penetrating abdominal trauma. N Engl J Med 1984; 31: 1065–70. 6 Dellinger EP, Oreskovich MR, Wertz MJ, Hamasaki V., Lennard ES. Risk of infection following laparotomy for penetrating abdominal injury. Arch Surg 1984; 119: 20–7. 7 Scott CM, Grasberger RC, Heeran TF, Williams LF, Hirsch EF. Intraabdominal sepsis after hepatic trauma. Am J Surg 1988; 155: 284–8. 8 Tartter PI, Quintero S., Barron DM. Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am J Surg 1986; 152: 479–82. 9 Medawar PB. Immunity to homologous grafted skin; relationship between antigens of blood and skin. Br J Exp Pathol 1945; 127: 15–24. 10 Medawar PB. Relationship between antigens of blood and skin. Nature 1946; 157: 161–2. 11 Halasz NA, Orloff MJ, Hirose F. Increased survival of renal homografts in dogs after injection of graft donor blood. Transplantation 1964; 2: 453–8. 12 Dossetor JB, MacKinnon KJ, Gault MH, MacLean LD. Cadaver kidney transplants. Transplantation 1967; 5: 844–53. 13 Jenkins AM, Woodruff MFA. The effect of prior administration of donor strain blood or blood constituents on the survival of cardiac allografts in rats. Transplantation 1971; 12: 57–60. 14 Marquet RL, Heystek GA, Tinbergen WJ. Specific inhibition of organ allograft rejection by donor blood. Transplant Proc 1971; 3: 708–10. 15 Fabre JW, Morris PJ. The effect of donor strain blood pretreatment on renal allograft rejection in rats. Transplantation 1972; 14: 608–17. 16 Opelz G., Mickey MR, Terasaki PI. Identification of unresponsive kidney-transplant recipients. Lancet 1972; 1: 868–71. 17 Opelz G., Sengar DPS, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253–9. 18 Salvatierra O. Jr, Vincenti F., Amend W., et al. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg 1980; 192: 543–52. 19 Glass NR, Miller DT, Sollinger HW, Belzer FO. Comparative analysis of the DST and imuran-plus-DST protocols for live donor renal transplantation. Transplantation 1983; 36: 636–41. 20 Newton WT, Anderson CB. Planned preimmunization of renal allograft recipients. Surgery 1973; 74: 430–6. 21 Okazaki H., Takahashi H., Miura K., Ishizaki M., Taguchi Y. Significant reduction of sensitization and improved allograft outcome with donor-specific buffy coat transfusion. Transplantation 1984; 37: 523–5. 22 Opelz G. Comparison of the transfusion effect in North America and Europe. Transplant Proc 1988: 20: 1069–70. 23 Mickey MR, Cats S., Graver B., Perdue S., Terasaki PI. Transfusion and selection in cadaveric donor kidney grafts. Transplant Proc 1983; 15: 965–8. 24 Van Lawick van Pabst WP, Langehorst BLAM, Mulder PGH, Marquet RL, Jeekel J. Effect of perioperative blood loss and perioperative blood transfusions on colorectal cancer survival. Eur J Cancer Clin Oncol 1988; 24: 741–7. 25 Blumberg N., Heal J., Chuang C., Murphy P., Agarwal M. Further evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence. Ann Surg 1988; 207: 410–5. 26 Polk HC Jr, George CD, Wellhausen SR, et al. A systematic study of host defense processes in badly injured patients. Ann Surg 1986; 204: 282–99. 27 Crile GW, Beebe SP. Transfusion experiments in dogs showing artificially implanted tumors. Proc Soc Exp Biol Med 1907; 4: 118–9. 28 Francis DMS, Burren CP, Clunie GJA. Acceleration of B16 melanoma growth in mice after blood transfusion. Surgery 1987; 102: 485–92. 29 Singh SK, Marquet RL, Westbroek DL, Jeekel J. Enhanced growth of artificial tumor metastases following blood transfusion: the effect of erythrocytes, leukocytes, and plasma transfusion. Eur J Cancer Clin Oncol 1987; 23: 1537–40. 30 Oikawa T., Hosokawa M., Imamura M., Sendo F., Nakayama M. Anti-tumour immunity by normal allogeneic blood transfusion in the rat. Clin Exp Immunol 1977; 27: 549–54. 31 Merrell SW, Shelby J., Freeman TR, Saffle JR. Effect of exchange transfusion on cell-mediated immune function following thermal injury. J Trauma 1988; 28: 184–9. 32 Waymack JP, Rapien J., Garnett D., Tweddell JS, Alexander JW. Effect of transfusion on immune function in a traumatized animal model. Arch Surg 1986; 121: 50–5. 33 Waymack JP, Warden GD, Alexander JW, Miskell P., Gonce S. Effect of blood transfusion and anesthesia on resistance to bacterial peritonitis. J Surg Res 1987; 42: 528–35. 34 Peugh WN, Wood KJ, Morris PJ. Genetic aspects of the blood transfusion effect. Transplantation 1988; 46: 438–43. 35 Snyder EL, Mosher DF, Hezzey A., Golenwsky G. Effect of blood transfusion on in vivo levels of plasma fibronectin. J Lab Clin Med 1981; 98: 336–41. 36 Wachtfogel YT, Abrams W., Kucich U., Weinbaum G., Schapira M., Colman RW. Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation. J Clin Invest 1988; 81: 1310–6. 37 Ozkan AN, Hoyt DB, Tompkins S., Ninnemann JL, Sullivan JJ. Immunosuppressive effects of a trauma-induced suppressor active peptide. J Trauma 1988; 28: 589–92. 38 Bottger EC, Hoffmann T., Metzger S., Hadding U., Bitter-Suermann D. The role and mechanism of cobra venom factor-induced suppression of the humoral immune response in guinea pigs. J Immunol 1986; 137: 1280–5. 39 Ogle JD, Ogle CK, Alexander JW. Inhibition of neutrophil function by fluid phase C3b of complement. Infect Immun 1983; 40: 967–76. 40 Krob MJ, Shelby J. Immunosuppressive effects of burn injury and nonspecific blood transfusion. Trauma 1986; 26: 40–3. 41 Kaplan J., Sarnaik S., Gitlin J., Lusher J. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984; 64: 308–10. 42 Stephan RN, Kisala JM, Dean RE, Geha AS, Chaudry IH. Effect of blood transfusion on antigen presentation function and on interleukin-2 generation. Arch Surg 1988; 123: 235–40. 43 Waymack JP, Balakrishnan K., McNeal N., et al. Effect of blood transfusions on macrophage-lymphocyte interaction in an animal model. Ann Surg 1986; 204: 681–5. 44 Tartter PI, Heimann TM, Aufses AH Jr. Blood transfusion, skin test reactivity, and lymphocytes in inflammatory bowel disease. Am J Surg 1986; 151: 358–61. 45 Schot JDL, Schuurman RKB. Blood transfusion suppresses cutaneous cell-mediated immunity. Clin Exp Immunol 1986; 65: 336–44. 46 Keown PA, Descamps B. Improved renal allograft survival after blood transfusion: a nonspecific, erythrocyte-mediated immunoregulatory process Lancet 1979; 1: 20–2. 47 Bryan CF, Leech SH. The immunoregulatory nature of iron. I. Lymphocyte proliferation. Cell Immunol 1983; 75: 71–9. 48 DeSousa M. Blood transfusions and allograft survival: iron-related immunosuppression? (letter). Lancet 1983; 2: 681–2. 49 Wood ML, Gottschalk R., Monaco AP. Effect of blood transfusion on IL-2 production. Transplantation 1988; 45: 930–5. 50 Lenhard V., Maassen G., Opelz G. Transfusion-induced enhancement of prostaglandin and thromboxane release in prospective kidney graft recipients. Proc Eur Dial Transplant Assoc Eur Ren Assoc 1984; 21: 923–7. 51 Waymack JP, Gallon L., Barcelli U., Trocki O., Alexander JW. Effect of blood transfusions on immune function. III. Alterations in macrophage arachidonic acid metabolism. Arch Surg 1987; 122: 56–60. 52 Jackson V., Tsakiris D., Tonner E., Briggs JD, Junor BJR. In vitro prostagladin E production following multiple blood transfusions in dialysis patients. Transplant Proc 1985; 17: 2386–8. 53 Shevach EM. The effects of cyclosporin A on the immune system. Annu Rev Immunol 1985; 3: 397–423. 54 Whisler RL, Lindsey JA, Proctor KVW, Morisaki N., Cornwell DC. Characteristics of cyclosporine induction of increased prostaglandin levels from human peripheral blood monocytes. Transplantation 1984; 38: 377–81. 55 Goodwin JS, Bankhurst AD, Messner RP. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med 1977; 146: 1719–34. 56 Lenhard V., Gemsa D., Opelz G. Transfusion-induced release of prostaglandin E2 and its role in the activation of T suppressor cells. Transplant Proc 1985; 17: 2380–2. 57 Foegh ML. Immune regulation by eicosanoids. Transplant Proc 1988; 20: 1158–61. 58 Snyder DS, Beller DI, Unanue ER. Prostaglandins modulate macrophage la expression. Nature 1981; 299: 163–5. 59 Walker C., Kristensen F., Bettens F., DeWeck AL. Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production. J Immunol 1983; 130: 1770–3. 60 Baker PE, Fahey JV, Munck A. Prostaglandin inhibition of T-cell proliferation is mediated at two levels. Cell Immunol 1981; 61: 52–61. 61 Shelby J. Transfusion-induced immunosuppression. J Burn Care Rehabil 1987; 8: 546–8. 62 Perez RV, Munda R., Alexander JW. Dietary immunoregulation of transfusion-induced immunosuppression. Transplantation 1988; 45: 614–7. 63 Klatzmann D., Gluckman JC, Foucault C., Bensussan A., Assobga U., Duboust A. Suppression of lymphocyte reactivity by blood transfusions in uremic patients. Transplantation 1983; 35: 332–8. 64 Tyler JD, Anderson CB, Sicard GA. Interleukin 2 response inhibition following donor specific transfusions given with azathioprine. Transplant Proc 1987; 19: 2258–61. 65 Stuart FP, Saitoh T., Fitch FW. Rejection of renal allografts: specific immunologic suppression. Science 1968; 160: 1463–5. 66 Roy R., Lachance JG, Noel R., Grose JH, Beaudoin R. Improved renal allograft function and survival following nonspecific blood transfusions. I. Induction of soluble suppressor factors inhibiting the mitogenic response. Transplantation 1986; 41: 640–3. 67 Smith MD, Williams JD, Coles GA, Salaman JR. Blood transfusions, suppressor T cells, and renal transplant survival. Transplantation 1983; 36: 647–50. 68 Baird MA, Heslop BF. The importance of specificity in the transfusion effect. Transplantation 1988; 45: 666–8. 69 Takiff H., Novak M., Yin L., Iwaki Y., Terasaki PI. Examination of the clonal deletion hypothesis following transfusions in rat cardiac transplants. Transplantation 1987; 43: 145–51. 70 Pfeffer PF, Thorsby E., Hirschberg H. Cell-mediated cytotoxicity toward the donor in patients with well-functioning kidney grafts. Possible mechanism of specifically reduced cytotoxic response. Transplantation 1983; 35: 546–51. 71 Lim SML, White DJG, Calne RY. Unresponsiveness to class I antigens is not equal to tolerance to class I antigens induced by cyclosporine A. Transplant Proc 1988; 20(Suppl 3): 1031–3. 72 Sato S., Azuma T., Shimizu J., et al. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogenic cells. J Immunol 1988; 141: 721–7. 73 Schad VC, Phipps RP. Two signals are required for accessory cells to induce B cell unresponsiveness. Tolerogenic Ig and prostaglandin. J Immunol 1988; 141: 79–84. 74 Levich JD, Signorella AP, Wittenberg G., Weigle WO. Macrophage handling of a tolerogen and the role of IL 1 in tolerance induction in a helper T cell clone in vitro. J Immunol 1987; 138: 3675–9. 75 Welsh KI, Burgos H., Batchelor JR. The immune response to allogeneic rat platelets; Ag-B antigens in matrix form lacking la. Eur J Immunol 1977; 7: 267–72. 76 Superina RA, Wood KJ, Morris PJ. The effect of pretreatment with a single cloned donor class I gene product on cardiac allograft survival in mice. Transplantation 1987; 44: 719–21. 77 Baird MA, Munn SR, Heslop BF. Immunosuppressive activity of class I antigens in the absence of antigen-presenting cells that are MHC-compatible with the host. Transplantation 1988; 46: 105–8. 78 Didlake RH, Kim EK, Kahan BD. Impact of a combined regimen of cyclosporine and 3M KCI extracted histocompatibility antigen on heterotopic rat cardiac allograft survival. Transplant Proc 1988; 20(Suppl 3): 1034–7. 79 Kamada N., Wight DGD. Antigen-specific immunosuppression induced by liver transplantation in the rat. Transplantation 1984; 38: 217–21. 80 Caulfield MJ, Shaffer D. Immunoregulation by antigen/antibody complexes. I. Specific immunosuppression induced in vivo with immune complexes formed in autibody excess. J Immunol 1987; 138: 3680–3. 81 Terness P., Opelz G. Suppression of antibody response to transfusions in rats by preconditioning with antibody-coated cells. Transplantation 1985; 40: 389–93. 82 Ptak W., Flood PM, Janeway CA Jr, Marcinkiewicz J., Green DR. Immunoregulatory role of Ig isotypes. I. Induction of contrasuppressor T cells for contact sensitivity responses by antibodies of the IgM, IgGl, and IgG3 isotypes. J Immunol 1988; 141: 756–64. 83 Ptak W., Janeway CA Jr, Flood PM. Immunoregulatory role of Ig isotypes. II. Activation of cells that block induction of contact sensitivity responses by antibodies of IgG2a and IgG2b isotypes. J Immunol 1988; 141: 765–73. 84 Heyman B., Wigzell H. Immunoregulation by monoclonal sheep erythrocyte-specific IgG antibodies: suppression is correlated to level of antigen binding and not to isotype. J Immunol 1984; 132: 1136–43. 85 Singal DP, Joseph S. Role of blood transfusions on the induction of antibodies against recognition sites on T lymphocytes in renal transplant patients. Hum Immunol 1982; 4: 93–108. 86 Lenhard V., Massen F., Seifert P., Johannsen R., Grosse-Wilde H. Characterization of transfusion-induced suppressor cells in prospective kidney allograft recipients. Transplant Proc 1982; 14: 329–32. 87 Jerne NK. Towards a network theory of the immune system. Ann Immunol (Paris) 1974; 1250: 373–89. 88 Shohat B., Cytron S., Boner C., Danon YL. Blocking antibodies and T cell subsets in long-term survivors of renal allografts. Transplantation 1987; 44: 34–7. 89 Chia D., Horimi T., Terasaki PI, Hermes M. Association of anti-Fab and anti-IgG antibodies with high kidney transplant survival. Transplant Proc 1982; 16: 322–4. 90 Forwell MA, Cocker JE, Peel MG, et al. Correlation between high-molecular-weight Fc gamma-receptor-blocking factors in serum and renal allograft survival. Transplantation 1987; 44: 227–33. 91 Burlingham WJ, Pan MH, Mason B., Ceman S., Sollinger HW. Induction of antiidiotypic antibodies to donor HLA-A2 following blood transfusions in a highly sensitized HLA-A2+ recipient. Transplantation 1988; 45: 1066–71. 92 Barkley SC, Sakai RS, Ettenger RB, Fine RN, Jordan SC. Determination of antiidiotypic antibodies to anti-HLA IgG following blood transfusions. Transplantation 1987; 44: 30–4. 93 Stewart KN, Power DA, Hills AN, Catto GRD. Antiidiotypic antibody activity in patients receiving donor specific transfusions and cyclosporin A. Transplant Proc 1987; 19: 2262–3. 94 Suciu-Foca N., Reed E., Rohowksy-Kochan C., et al. Idiotypic network regulations of the immune response to HLA. Transplant Proc 1985; 17: 716–9. 95 Reed E., Hardy M., Benvenisty A., et al. Effect of antiidiotypic antibodies to HLA on graft survival in renal allograft recipients. N Engl J Med 1987; 316: 1450–5. 96 Leivestad T., Thorsby E. Effects of HLA-haploidentical blood transfusions on donor-specific immune responsiveness. Transplantation 1984; 37: 175–81. 97 Nagata M., Ochiai T., Asano T., et al. Role of IA-positive cells in the beneficial effect of donor blood transfusions and induction of suppressor cells in cardiac allotransplantation of rats. Transplantation 1984; 38: 522–6. 98 Sy MS, Miller SD, Kowach HB, Claman HN. A splenic requirement for the generation of suppressor T cells. J Immunol 1977; 119: 2095–9. 99 Hutchinson IV. Suppressor T cells in allogeneic models. Transplantation 1986; 41: 547–55. 100 Rich RR, ElMasry MN, Fox EJ. Induction of suppressor T cells by cytokines. Transplant Proc 1988; 20: 1156–7. 101 Gorczyynski RM, Boulanger M., Lau C. T-cell derived factor alone or in combination with immunosuppressive drugs augments prolongation of allogeneic skin graft survival in mice receiving donor-specific transfusion. J Immunol 1987; 138: 3197–202. 102 Loertscher R., Leichman AB, Williams JM, Strom TB. Blocking of T cell activation at the GlA/GIB interface of the cell cycle and prevention of expression of interleukin 2 receptors by alloactivated suppressor T lymphocytes. Transplantation 1988; 45: 194–201. 103 Ptak W., Zembala M., Asherson GL, Marcinkiewicz J. Inhibition of contact sensitivity by macrophages. Int Arch Allergy Appl Immunol 1981; 65: 121–8. 104 Opelz G., Terasaki PI. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med 1978; 299: 799–803. 105 Gupta S., Grieco MH, Siegel I. Suppression of T-lymphocyte rosettes by rifampin. Studies in normals and patients with tuberculosis. Ann Intern Med 1975; 82: 484–8. 106 Schwartz J., Charpentier B., Lang P., Martin B., Fries D. Immunosuppressive property of Rifampicin antagonizes the beneficial effect of blood transfusion in rat organ allografting. Transplantation 1982; 34: 155–6. 107 Mickelson EM, Bean MA, Ishioka S., Hansen JA. Monitoring alloimmune responses in vivo following donor-specific transfusion: generation of suppressor T cells and alterations in alloreactive precursor frequencies. Transplant Proc 1985; 17: 2389–92. 108 Phipps RP, Scott DW. A novel role for macrophages: the ability of macrophages to tolerize B cells. J Immunol 1983; 131: 2122–7. 109 Rao VK, Burris DE, Gruel SM, Sollinger HW, Burlingham WJ. Evidence that donor spleen cells administered through the portal vein prolong the survival of cardiac allografts in rats. Transplantation 1988; 45: 1145–6. 110 Gugenheim J., Charpentier B., Gigou M., et al. Delayed rejection of heart allografts after extracorporeal donor-specific liver hemoperfusion. Role of Kupffer cells. Transplantation 1988; 45: 628–32. 111 Light JA, Metz S., Oddenino K., et al. Donor-specific transfusion with diminished sensitization. Transplantation 1982; 34: 352–5. 112 Balshi JD, Francfort JW, Perloff J. The influence of ultraviolet irradiation on the blood transfusion effect. Surgery 1985; 98: 243–50. 113 Martinelli GP, Horowitz C., Chiang K., Racelis D., Schanzer H. Pretransplant conditioning with donor-specific transfusions using heated blood and cyclosporine. Preservation of the transfusion effect in the absence of sensitization. Transplantation 1987; 43: 140–5. 114 Oluwole SF, Chabot J., Pepino P., Reemtsma K., Hardy M. Mechanisms of immunologic unresponsiveness induced by ultraviolet-irradiated donor-specific blood transfusions and peritransplant cyclosporine. Transplantation 1988; 46: 352–8. 115 Katz MR, Barnhart GR, Goldman MH, et al. Pretransplant transfusions in cardiac allograft recipients. Transplantation 1987; 43: 499–501. 116 Kerman R., Van Buren CT, Lewis RM, Frazier OH, Cooley D., Kahan BD. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine. Transplantation 1988; 45: 333–7. 117 Guttman RD, Lindquist RR, Kawabe K., Ockner SA. Renal transplantation in the inbred rat. XVII. Further observations on the induction of enhancement by active immunization. Transplantation 1972; 13: 15–7. 118 Goulmy E., Blokland E., Persijn G., Paul LC, Wilmink J., Van Rood JJ. HLA regulates postrenal transplant CML nonreactivity. J Immunol 1985; 135: 3082–6. 119 Hutchinson IV, Morris PJ. The role of major and minor histocom-patibility antigens in active enhancement of rat kidney allograft survival by blood transfusion. Transplantation 1986; 41: 166–70. 120 Lundgren G., Groth CG, Albrechtsen D., et al. HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation — a changing picture with cyclosporin. Lancet 1986; 2: 66–9. 121 Perez RV, Heyd TJ, Munda R., Babcock GF, Alexander JW. Induction of long-term rat cardiac allograft survival in rats with multiple donor specific transfusions and cyclosporine. Curr Surg 1988; 45: 9–12. 122 Padberg WM, Lord RH, Araneda D., Tilney NL, Kupiec-Weglinski JW. Synergistic immunosuppressive effect of subtherapeutic doses of cyclosporine A on immunologic enhancement in rat recipients of cardiac allografts. Transplant Proc 1988; 20(Suppl 3): 1053–6. 123 Martin DC, Dowdy SF, Hewitt C., Black KS, Dominguez D., Gonzalez GA. Comparison of renal allograft survival in rats pretreated with multiple blood transfusions combined with either cyclosporine or azathioprine. Transplant Proc 1985; 17: 1087–90. 124 Jones MC, Power DA, Cunningham C., Catto GRD. The influence of repeated transfusions and cyclosporine on secondary alloantibody responses in inbred rats. Transplantation 1988; 45: 1094–9. 125 Yoshimura N., Kahan BD. The immunosuppressive action of suppressor cells from antigen-cyclosporine-treated hosts on renal allograft survival. Transplantation 1985; 40: 384–9. 126 Tchervenkov JI, Epstein MD, Alexander JW, Schroeder TJ. The effect of donor-specific blood transfusions, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival. Transplantation 1989; 47: 177–81. 127 Weiden PL, Bean MA, Schultz P. Perioperative blood transfusion does not increase the risk of colorectal cancer recurrence. Cancer 1987; 60: 870–4. 128 Hyman NH, Foster RS, DeMeules JE, Costanza MC. Blood transfusions and survival after lung cancer resection. Am J Surg 1985; 149: 502–7. 129 Martin DC, Hewitt CW. Enhancement of rat renal allografts with various immunogens. Invest Urol 1981; 18: 406–8. Citing Literature Volume30, Issue7September 1990Pages 651-658 ReferencesRelatedInformation
Publication Year: 1990
Publication Date: 1990-09-01
Language: en
Type: review
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 209
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot